MST1 and metabolic dysfunction-associated steatohepatitis: Experimental analyses demonstrate that NASH models (both animal and cellular systems) exhibit concurrent activation of cholesterol biosynthesis pathways, hepatic FC accumulation, and progressive inflammatory/fibrotic responses, accompanied by diminished MST1 expression.